These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 8909308

  • 1. Postoperative immunostimulation after complete resection improves survival of patients with stage I nonsmall cell lung carcinoma.
    Fujisawa T, Yamaguchi Y.
    Cancer; 1996 Nov 01; 78(9):1892-8. PubMed ID: 8909308
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Randomly controlled study of chemotherapy versus chemoimmunotherapy in postoperative lung cancer patients.
    Yasumoto K, Yaita H, Ohta M, Azuma I, Nomoto K, Inokuchi K, Yamamura Y.
    Cancer Res; 1985 Mar 01; 45(3):1413-7. PubMed ID: 3155992
    [Abstract] [Full Text] [Related]

  • 4. [Effect of adjuvant immunotherapy with Nocardia rubra cell-wall skeleton in lung cancer].
    Yasumoto K, Ichinose Y, Yaita H, Tanaka K, Hara N, Ohta M, Hirota N, Nomoto K, Inokuchi K, Yamamura Y.
    Nihon Geka Gakkai Zasshi; 1983 Apr 01; 84(4):321-7. PubMed ID: 6325864
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Transfer factor immunochemotherapy for primary lung cancer--evaluation of histologic types].
    Fujisawa T, Yamaguchi Y.
    Gan No Rinsho; 1983 Oct 01; 29(12):1409-16. PubMed ID: 6315989
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Randomized clinical trial of non-specific immunotherapy with cell-wall skeleton of Nocardia rubra.
    Yasumoto K, Yamamura Y.
    Biomed Pharmacother; 1984 Oct 01; 38(1):48-54. PubMed ID: 6380607
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Stage IB nonsmall cell lung cancers: are they all the same?
    Jones DR, Daniel TM, Denlinger CE, Rundall BK, Smolkin ME, Wick MR.
    Ann Thorac Surg; 2006 Jun 01; 81(6):1958-62; discussion 1962. PubMed ID: 16731113
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Postoperative adjuvant cisplatin, vindesine, plus uracil-tegafur chemotherapy increased survival of patients with completely resected p-stage I non-small cell lung cancer.
    Imaizumi M, Study Group of Adjuvant Chemotherapy for Lung Cancer (Chubu, Japan).
    Lung Cancer; 2005 Jul 01; 49(1):85-94. PubMed ID: 15949594
    [Abstract] [Full Text] [Related]

  • 16. [Evaluation of postoperative immunotherapy of gastric cancer].
    Ochiai T, Sato H.
    Gan To Kagaku Ryoho; 1983 Feb 01; 10(2 Pt 2):373-9. PubMed ID: 6349536
    [Abstract] [Full Text] [Related]

  • 17. Prognostic factors in resected stage I non-small cell lung cancer with a diameter of 3 cm or less: visceral pleural invasion did not influence overall and disease-free survival.
    Hung JJ, Wang CY, Huang MH, Huang BS, Hsu WH, Wu YC.
    J Thorac Cardiovasc Surg; 2007 Sep 01; 134(3):638-43. PubMed ID: 17723811
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.